CTRI/2024/11/077473招募中不适用
Multi-omics Strategies to Improve Clinical Outcomes in Uveitis LOTUS – Leveraging Ocular Tissues in Uveitis Study
Proctor Foundation University of California1 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2024年12月10日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 600
- 试验地点
- 1
- 主要终点
- Correct identification of the pathogen will change the treatment modality
研究概览
简要总结
LOTUS is a study that combines multimodality molecular approaches to improve the diagnosis of uveitis by characterizing pathogens, host transcriptomes, the proteome and metaboite signatures in uveitis.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2.00 Year(s) 至 80.00 Year(s)（—）
- 性别
- All
入选标准
- •Intraocular samples a) Presumed active infectious uveitis b) Endophthalmitis c) Unilateral or Bilateral Tear samples a) Active or inactive uveitis b) Unilateral or Bilateral.
排除标准
- •Intraocular samples a) Insufficient sample size b) Inability to give consent Tear samples a) Inability to give consent.
结局指标
主要结局
Correct identification of the pathogen will change the treatment modality
时间窗: 3 months
次要结局
未报告次要终点
研究者
Dr Rathinam Sivakumar
Aravind Eye Hospital and Postgraduate Institute of Ophthalmology
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Comprehensive Multi-omics Characterization and Implications of Non-Pharmaceutical Dental Hygiene Product in a Randomized Controlled Large Population Study.NCT07451782Delta Dental of Minnesota Foundation595
尚未招募
不适用
An Integrated Multi-omics Study on the Molecular Mechanisms of Ureteral StrictureUreteral ObstructionUreteral StrictureNCT07409870First Affiliated Hospital of Chongqing Medical University120
尚未招募
不适用
Multi-Omics Integrative Analysis of Serum and Sputum to Uncover Key Determinants of Prognosis in Patients With ARDSNCT07380997Ruijin Hospital411
招募中
不适用
Feasibility of a Multi-omics Platform for Hematological MalignanciesAcute LeukemiaNCT07445438Azienda Ospedaliero-Universitaria di Parma1,040
招募中
不适用
Application and Exploration of Personalized ctDNA-MRD Detection Technology in Predicting the Efficacy of Neoadjuvant Therapy for Rectal CancerNCT07393048Beijing Friendship Hospital60